M A Asenjo Selected Research

Inflexal V

5/2009

Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Asenjo Research Topics

Disease

2	Infections 02/2008 - 11/2000
1	Human Influenza (Influenza) 05/2009
1	Malocclusion (Crossbite) 05/2009
1	Calculi (Calculus) 05/2009
1	Hemorrhage 05/2009
1	Exanthema (Rash) 04/2008
1	Ventilator-Associated Pneumonia 02/2008
1	Tetanus 12/2001
1	Diphtheria 12/2001
1	Pneumonia (Pneumonitis) 11/2000
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2000
1	Chronic Bronchitis 11/2000

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 05/2009 - 12/2001
1	Inflexal VIBA 05/2009
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2009
1	Nevirapine (Viramune)FDA Link 04/2008
1	ProcalcitoninIBA 02/2008
1	C-Reactive ProteinIBA 02/2008
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 12/2001
1	AntibodiesIBA 12/2001
1	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 12/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2000
1	beta-LactamsIBA 11/2000
1	MacrolidesIBA 11/2000
1	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2000
1	FluoroquinolonesIBA 11/2000

Therapy/Procedure

1	Orthodontic Appliances 05/2009
1	Therapeutics 11/2000